期刊文献+

重组胰高血糖素样多肽2对烧伤大鼠肠黏膜的保护作用 被引量:2

The protective effect of recombinant glucagons like peptide-2 on intestinal mucosa of burn rats
原文传递
导出
摘要 目的验证重组胰高血糖素样多肽2(GLP-2)对严重烧伤大鼠的肠道保护作用。方法将SD大鼠随机分为正常对照组;烧伤对照组;重组GLP-2治疗组(重组治疗组),烧伤后4 h皮下注射重组GLP-2,100 nmol·kg^(-1)·d^(-1);化学合成GLP-2治疗组(合成治疗组),烧伤4 h后皮下注射合成GLP-2,剂量同上。每组6只大鼠。伤后第7天检测各致伤组大鼠肠黏膜通透性、肠黏膜湿质量与肠段及躯壳质量比、肠黏膜蛋白含量以及观察肠道组织病理学变化,正常对照组观察指标相同。结果重组治疗组及合成治疗组与烧伤对照组[(0.350±0.040)mg/ml]比较,大鼠肠黏膜通透性明显降低(P<0.01),分别为(0.250±0.026)、(0.243±0.008)mg/ml;肠黏膜湿质量与躯壳质量比及肠黏膜蛋白含量明显增加,重组治疗组大鼠肠黏膜蛋白含量为(57.9±2.8)mg/g,高于合成治疗组(48.9±4.1)mg/g。与正常对照组比较,各致伤组大鼠伤后第7天肠黏膜绒毛明显变短脱落、排列紊乱、基底层变薄。重组治疗组损伤较烧伤对照组有所减轻,与合成治疗组大鼠无明显区别。结论重组GLP-2与合成GLP-2,能减轻烧伤大鼠肠道损伤,具有明显的肠道保护作用。 Objective To investigate the protective effect of recombinant g]ucagons like peptide-2 (GLP-2) on intestinal mucosa of rats with severe burns. Methods SD rats of either sex were randomly di- vided into 4 groups: normal control( N ,n = 6) , burn control group( C, n = 6) , recombinant GLP-2 group (Gr, n =6,with subcutaneous injection of 100nmol·kg^-1·d^-1 recombinant GLP-2 at 4 post-burn hours (PBH) and synthesized GLP-2 group( G, n = 6, with subcutaneous injection of 100 nmol·kg^-1·d^-1 synthesized GLP-2 at 4 PBH) . Except the normal control group, all animals in the other groups received a 30% TBSA third degree burns, the rats were sacrificed on 7 postburn days(PBD) and the following indexes were determinedpathological examination of intestinal mucosa, mucosa permeability of intestinal mucosa, the ratio of mucosa wet weight and bowel mass or carcase weight, and the protein content of intestinal mucosa. Results Compared with that in burn group[ (0. 350 ± 0. 040)mg/ml] , the mucosa permeability significantly decreased in Gr (0. 250-± O. 026) mg/ml and G (0. 243 ± O. 008) mg/ml groups, while the ratio of mucosa wet weight and carcase weight, the protein content of intestinal mucosa were significantly increased. In additon, the content of intestinal mucosal protein in Gr group[ (57.9 ± 2.8 )mg/g wet weight] was higher than that in G group[ (48.9 ±4.1 )mg/g wet weight]. In contrast to normal controls, the villi of intestinal mucosa in rats on 7 PBD were obviously shortened and exfoliated, with deranged disposition and thinned basal membrane. No obvious difference of the injury was observed between Gr and G groups, and the injury was milder when compared with burn group. Conclusion Recombinant GLP-2, as well as synthesized GLP-2, exhibits obvious protective effect on intestinal mucosa in alleviating injury to intestinal mucosa in burn rats.
出处 《中华烧伤杂志》 CAS CSCD 北大核心 2007年第4期253-256,共4页 Chinese Journal of Burns
基金 国家青年科学基金(30600212)
关键词 烧伤 肠黏膜 胰高血糖素样多肽2 肠道保护 Burns Intestinal mucosa Glucagons like peptide-2 Enteroprotection
  • 相关文献

参考文献13

  • 1Drucker DJ, Erlich P, Asa SL, et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci, 1996,93 ( 7 ) :7911 - 7916.
  • 2Benjamin MA, MeKay DM, Yang PC, et. al. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut,2000,47( 1 ) : 112 - 119.
  • 3王凤君,赵云,王裴,汪仕良,刘敬,周新.胰高血糖素样肽-2对严重烧伤大鼠肠黏膜屏障功能的影响[J].世界华人消化杂志,2002,10(7):796-799. 被引量:12
  • 4Gleeson MH, Bloom SR, Polak JM. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut,1971,12(2) :773 -782.
  • 5Martin GR. WaLlace LE, Sigalet DL. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol, 2004, 286( 3 ) :964 -972.
  • 6Shin ED, Estall JL,Izzo A, at al. Mueosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gasteroenterology, 2005, 128 (5) : 1340 - 1353.
  • 7Jasleen JN, Ashley SW, Shimoda N ,et al. Glueagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro. Dig Dis Sci,2002, 47(5): 1135-1140.
  • 8Jeppesen PB, Hartmann B ,Thulesen J,et. al. Glucagonlike peptide 2 improves nutrient absorption and nutritional status in shortbowel patients with no colon. Gastroenterology, 2001,120(3) :806-815.
  • 9Burrin DG, Stoll B, Jiang R, et al. GLP-2 stimulates intestinal growth inpremature TPN-fed pigs by suppressing proteolysis and apoptosis. Am J Physiol ( Gastrointest Liver Physiol) , 2000, 279 (7) :1249 - 1256.
  • 10赵云,王凤君,王裴,汪仕良.胰高血糖素样肽-2对大鼠烧伤后肠粘膜上皮细胞凋亡的影响[J].第三军医大学学报,2002,24(7):764-766. 被引量:10

二级参考文献24

  • 1F.奥斯伯 颜子颖(译).精编分子生物学实验指南[M].北京:科学出版社,1998.141.
  • 2Drucker DJ, Erlich P, Asa SL, et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci ,1996,93:7911 - 7916.
  • 3Burrin DG, Stoll B,Guan X . Glucagon-like peptide 2 function in domestic animals. Domest Anim Endoctinol, 2003, 24:103 -122.
  • 4Hosida NB, Masahur N, Manabu K, et al. Structural and functional alterations in the gut of parenterally or enterally fed rats. J Surgical Research, 1989, 47:129 - 133.
  • 5Drucker D J, Boushey RP, Wang F, et al. Biologic properties and therapeutic potential of glucagon-like peptide-2. JPEN, 1999 ,23Suppl:98 - 100.
  • 6Brubaker PL, Crivici A ,Izzo A, et al. Circulating and tissue forms of the intestinal cell lines. Regul Pept, 1996, 62:29 -35.
  • 7Brubaker PL, Izzo A, Hill M, et al. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol, 1997, 272 : 1050 - 1058.
  • 8Benjamin MA, McKay DM, Yang PC, et al. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut, 2000, 47:112 - 119.
  • 9Hussain MA. A biological function for glucagon-like peptide-2. Eur J Endocrinol, 1998, 139:265 - 267.
  • 10Yusta B, Somwar R, Wang F, et al. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor. J Biol Chem,1999,274 : 30459 - 30467.

共引文献28

同被引文献13

  • 1Marja-Leena Kylnp,Heikki Repo,Pauli Antero Puolakkainen.Inflammation and immunosuppression in severe acute pancreatitis[J].World Journal of Gastroenterology,2010,16(23):2867-2872. 被引量:101
  • 2Matteo Piciucchi,Elettra Merola,Massimo Marignani,Mari-anna Signoretti,Roberto Valente,Lucia Cocomello,Flavia Baccini,Francesco Panzuto,Gabriele Capurso,Gianfranco Delle Fave.Nasogastric or nasointestinal feeding in severe acute pancreatitis[J].World Journal of Gastroenterology,2010,16(29):3690-3696. 被引量:14
  • 3王新宇,石现,何磊.电针对急性胰腺炎患者胃肠动力的影响及其机制研究[J].针刺研究,2007,32(3):199-202. 被引量:44
  • 4Burrin DG, Stoll B, Guan X. Glucagon-like peptide 2 function in domestic animals [J]. Domest Anim Endocrinol, 2003, 24 (2) : 103-122.
  • 5Burrin DG, Stoll B, Guan X, et al. Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets[J] Endocrinology, 2005,146 ( 1 ) : 22- 32.
  • 6Torres S, Thim L, Milliat F, et al. Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis inthe rat[J]. Int J Radiat Oncol Biol Phys,2007,69(5): 1563- 1571.
  • 7Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal[J]. Arch Surg, 1970,101 (4) : 478- 483.
  • 8Diepenhorst GM, van Gulik TM, Hack CE. Complementmediated isehemia-reperfusion injury:lessons learned from animal and clinical studies[J]. Ann Surg, 2009,249(6) : 889- 899.
  • 9Boushey RP, Yusta B, Drucker DJ. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin- induced murine enteritis [J ]. Am J Physiol Endocfinol Metab, 1999,277(5) : 937-947.
  • 10Tavakkolizadeh A, Shen R, Abraham P, et al. Glucagon-like peptide 2..a new treatment for chemotherapy-induced enteritis [J]. J Surg Res,2000,91(1).-77-82.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部